Skip to content

Clinical trials

Completed Hypersensitivity trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Status: Completed Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20141
20181
20201
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Ellodi Pharmaceuticals, LP2
Diag-Nose Medical Pty Ltd1
Faes Farma, S.A.1
GlaxoSmithKline1
Murdoch Childrens Research Institute1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity10
Eosinophilia4
Eosinophilic Esophagitis4
Esophageal Diseases4
Esophagitis4
Gastroenteritis4
Gastrointestinal Diseases4
Hypersensitivity, Immediate3
Immune System Diseases3
Eczema2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.